ArticleTherapeutic advances in musculoskeletal disease2022

Effectiveness and safety of secukinumab in axial spondyloarthritis: a 24-month prospective, multicenter real-life study.

Roberta Ramonda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.